Coprocessing: A Robust Platform to Optimize Solubility & Bioavailability | AIChE

Coprocessing: A Robust Platform to Optimize Solubility & Bioavailability

As therapies become more complex, so do the obstacles that can interfere with their delivery. A robust solution to inadequate drug solubility, powder flow, and bioavailability, continuous co-processing is a platform that can be applied across various molecule classes and formulation types. Utilizing both classical and innovative techniques, co-processing has the added benefit of expediting manufacture of materials needed for toxicology screens and clinical studies. Additionally, co-processing assures the scale up of many energetic and sensitive processes, thus allowing for a safe and rugged technical transfer. This technical showcase will highlight how the co-processing platform and methodology behind it can be your next solution to drug development and delivery. Learning Objectives: - Understand what is Co-processing, the latest technologies used in the technique, as well as the most up-to-date regulatory status - Discover the ongoing industry efforts to promote this technology - Learn some of the common techniques used on the co-processing technology platform - Know some example(s) of how the use of co-processing can improve powder flow and density - Know some example(s) of how the use of co-processing can improve formulation process ruggedness

Presentations

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00